Abstract
摘要
相似文献
1
Multidrug-resistant tuberculosis.耐多药结核病
Wkly Epidemiol Rec. 2001 Sep 7;76(36):273.
2
Drug-resistant tuberculosis: desperate measures?耐药结核病：孤注一掷的措施？
Lancet. 2001 Apr 7;357(9262):1124. doi: 10.1016/S0140-6736(00)04268-9.
3
Public health. Responding to market failures in tuberculosis control.公共卫生。应对结核病控制中的市场失灵。
Science. 2001 Aug 10;293(5532):1049-51. doi: 10.1126/science.1061861. Epub 2001 Jul 19.
4
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.控制耐多药结核病与获取昂贵药物：一个合理框架
Bull World Health Organ. 2002;80(6):489-95; discussion 495-500.
5
Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran.治疗成本在耐多药结核病传入伊朗中的作用
Clin Infect Dis. 2015 Sep 15;61(6):1029-30. doi: 10.1093/cid/civ459. Epub 2015 Jun 9.
6
Time to put boots on the ground: making universal access to MDR-TB treatment a reality.是时候采取实际行动了：让耐多药结核病治疗普及成为现实。
Int J Tuberc Lung Dis. 2010 Oct;14(10):1222-5.
7
Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era?社论：耐多药结核病的治疗——回归抗生素前时代？
Trop Med Int Health. 2006 Nov;11(11):1625-8. doi: 10.1111/j.1365-3156.2006.01770.x.
8
Response to drug resistant tuberculosis is insufficient and too slow.对耐药结核病的反应不足且过于缓慢。
BMJ. 2011 Mar 28;342:d1969. doi: 10.1136/bmj.d1969.
9
TB drug prices slashed for poor countries.面向贫穷国家大幅削减结核病药物价格。
Bull World Health Organ. 2001;79(9):904-5. Epub 2001 Oct 23.
10
Epidemiology of multidrug-resistant tuberculosis.耐多药结核病的流行病学
Rays. 1998 Jan-Mar;23(1):15-8.
Zotero 插件